Bio-Rad Laboratories, Inc. (BIO) has entered a pronounced short-term downtrend, evidenced by a 12.6% drop over the past five trading days and a 10.1% decline over 20 days. The stock's price, recently around 253, has fallen below its rising 20-day SMA while lagging broader market performance. Longer-term, the trend remains neutral, with the price in the middle of its 52-week range (211-343). Over the last 30 days, BIO has traded in a 270-313 range, now approaching the lower end amid consolidation and pullback.
Traders are monitoring pivot-based supports at 245.35 (S1) and 239.19 (S2) on the classic method, with a key zone from 256-268 providing nearby demand. Resistance begins at 254.90 (R1), followed by clusters at 282-290 and 299-306. These levels align with recent consolidation lows and potential rebound points, where prior price action has shown reactions.
All simple and exponential moving averages signal sell on the daily timeframe, with the price below the MA5 (256), MA20 (272), MA50 (280), MA100 (289), and MA200 (282). The 50-day MA at 277-280 and 200-day at 282-292 act as overhead hurdles, reinforcing bearish bias as shorter-term averages trend lower relative to longer ones. This configuration underscores downward pressure across timeframes.
Momentum favors bears, with RSI(14) deeply oversold at 26.8 and Williams %R at -75.2 confirming exhaustion. MACD(12,26) at -7.27 reflects sustained selling, supported by a CCI(14) reading of -132 and ADX(14) of 41.2 indicating trend strength. Stochastics near oversold at 12.6 adds to potential reversal watch, though neutral STOCH(9,6) tempers immediate bullish divergence.
Price action over the last quarter shows declines totaling 4.6% over three months, punctuated by lighter volume during the recent pullback. This suggests waning seller conviction at current lows, with oversold conditions and support tests forming a potential double bottom setup in community analyses. Volatility remains medium at ATR(14) 5.49, focusing attention on key zones.
Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast market data, technical indicators, and recurring price patterns for Bio-Rad Laboratories, Inc. (BIO). These signals draw from trend recognition, momentum shifts, and historical behaviors to flag potential buy or sell opportunities. Traders rely on them to pinpoint entry/exit points, validate trend strength, and refine strategies amid volatile conditions. By automating complex analysis, the AI aids in navigating BIO’s chart dynamics efficiently. Explore the latest signals for informed decision-making.
Market participants eye a potential stabilization near supports at 239-245, where oversold RSI and Stochastics could spark a bounce toward 255 resistance. A break above 272-280 MAs would signal short-term relief, while failure at lower pivots risks deeper tests. Monitor MACD for crossover shifts and volume for confirmation of direction. Key zones include 256-268 demand and 282-290 supply.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
A.I.dvisor indicates that over the last year, BIO has been closely correlated with A. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIO jumps, then A could also see price increases.
| Ticker / NAME | Correlation To BIO | 1D Price Change % |
|---|---|---|
| BIO | 100% | +0.84% |
| BIO (3 stocks) | 94% Closely correlated | +0.25% |
| Health Services (246 stocks) | 3% Poorly correlated | +2.61% |
| Medical/Nursing Services (139 stocks) | 2% Poorly correlated | +2.63% |